Cormorant Asset Management LP

Search
⚲

Message
Happy Holidays!! thanks for using AUM13F!!

Cormorant Asset Management LP ✚
CRD #	167820
SEC #	801-79513
CIK #	0001583977
AUM	$3.9 B (2025-03-31)
Employees	12 (25% Investors, 0% Brokers)
Phone	857-702-0370
Address	200 Clarendon Street Boston, MA 02116
Source	[IAPD] [EDGAR] [LinkedIn]

Total AUM ($B) Copy

CIK	Period
0001583977	2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31

CIK

Period

0001583977

Sector	Form 13F Holdings	Value ($B)
	Helix Acquisition Corp	0.4
	Psivida Corp	0.1
	Bridgebio Pharma Inc	0.1
	Praxis Precision Medicines Inc	0.1
	Merus NV	0.1
	Edgewise Therapeutics Inc	0.1
	Insmed Inc	0.1
	Arcellx Inc	0.1
	Newamsterdam Pharma Co NV	0.0
	Janux Therapeutics Inc	0.0
	Rapport Therapeutics Inc	0.0
	Verona Pharma PLC	0.0
	Helix Acquisition Corp II	0.0
	Bright Minds Biosciences Inc	0.0
	Centessa Pharmaceuticals PLC	0.0
	Pharvaris NV	0.0
	GH Research PLC	0.0
	Silverback Therapeutics Inc	0.0
	Corbus Pharmaceuticals Holdings Inc	0.0
	Abivax Sa	0.0
	CG Oncology Inc	0.0
	Arcutis Biotherapeutics Inc	0.0
	Cargo Therapeutics Inc	0.0
	Tarsus Pharmaceuticals Inc	0.0
	Crinetics Pharmaceuticals Inc	0.0
	Metsera Inc	0.0
	Aardvark Therapeutics Inc	0.0
	Axsome Therapeutics Inc	0.0
	Bioage Labs Inc	0.0
	Engene Holdings Inc	0.0
Prev \| Page 1 \| Next

Type	Form D Funds	Date	Sold ($M)	AUM ($M)
PE	Cormorant Private Healthcare Fund V LP	[2023-11-13]	318.0	446.6
PE	Cormorant Private Healthcare Fund IV LP	[2021-11-15]	252.7	487.1
PE	Cormorant Private Healthcare Fund III LP	[2020-11-27]	206.3	616.9
PE	Cormorant Private Healthcare Fund II LP	[2018-11-26]	93.2	248.3
PE	Cormorant Private Healthcare Fund I LP	[2016-03-30]	0.0	31.9
HF	Cormorant Global Healthcare Master Fund LP	[2013-06-14]	631.8	2,020.3

AUM Breakdown	Accounts	AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	0	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	13	3.9
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	1	0.0
Total	14	3.9
By Discretionary
Discretionary	14	3.9
Non-Discretionary	0	0.0
Total	14	3.9
By Non-United States Persons
Non-United States Persons		0.8
United States Persons		3.1
Total	14	3.9

Form D Directors	# Filings	# Firms	2011 - 2025
Jay Scollins	17
Bihua Chen	43
Cormorant Asset Management LP	10
Caleb Tripp	6
Cormorant Asset Management LLC	4
Cormorant Private Healthcare GP LLC	2
Cormorant Private Healthcare GP III LLC	2
Neb Obradovic	2
Cormorant Private Healthcare GP II LLC	2
Cormorant Private Healthcare GP IV LLC	2
View All

EDGAR Form	CIK	2011 - 2025
13F-HR	[0001583977]
3	[0001583977]
4	[0001583977]
SC 13D	[0001583977]
SC 13G	[0001583977]

Form 13D/13G Filer	Form 13D/13G Subject	Filed
Cormorant Asset Management LP	Cabaletta Bio Inc	[2025-08-14]
Cormorant Asset Management LP	Cargo Therapeutics Inc	[2025-05-15]
Cormorant Asset Management LP	Bioage Labs Inc	[2025-02-14]
Cormorant Asset Management LP	Kala Bio Inc	[2025-02-14]
Cormorant Asset Management LP	Bright Minds Biosciences Inc	[2024-10-22]
Cormorant Asset Management LP	Onkure Therapeutics Inc	[2024-10-11]
Cormorant Asset Management LP	Rapport Therapeutics Inc	[2024-06-20]
Cormorant Asset Management LP	CytomX Therapeutics Inc	[2024-05-13]
Cormorant Asset Management LP	TScan Therapeutics Inc	[2024-04-29]
Cormorant Asset Management LP	Ventyx Biosciences Inc	[2024-03-21]
View All

Form 3/4/5 Subject	2011 - 2025
Cormorant Global Healthcare Master Fund, LP
Chen Bihua
Biomea Fusion, Inc.
Cormorant Asset Management, LP
Cormorant Private Healthcare Fund III LP
Cormorant Private Healthcare Fund V LP
OnKure Therapeutics, Inc.
Cormorant Private Healthcare Fund IV LP
Aardvark Therapeutics, Inc.
Bright Minds Biosciences Inc
View All

Comparable Firms	State	AUM ($B)
Indus Capital Partners LLC ✚	NY	4.0
Investcorp Corsair Infrastructure Partners LP ✚	NY	4.0
Skyknight Capital LP ✚	CA	4.0
Fundamental Advisors LP ✚	NY	4.0
Wildcat Capital Management LLC ✚	NY	3.9
HC Capital Partners LLC ✚	PA	3.9
Tinicum Incorporated ✚	NY	3.8
Bardin Hill Investment Partners LP ✚	NY	3.8
Caxton Associates USA LLC ✚	NY	3.7
Deer Park Road Management Company LP ✚	CO	3.7

{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}

Cormorant Asset Management LP

Assets, Funds, Holdings